USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
Taiwan
95132202
Filed on 2006-08-31
95132202
Filed on 2006-08-31
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
Thailand
601004157
Filed on 2006-08-30
601004157
Filed on 2006-08-30
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
Philippines
1-2008-500508
Filed on 2006-08-30
1-2008-500508
Filed on 2006-08-30
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
New Zealand
566424
Filed on 2008-03-04
566424
Filed on 2008-03-04
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
Norway
20081574
Filed on 2006-08-30
20081574
Filed on 2006-08-30
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
Mexico
MX/a/2008/003100
Filed on 2006-08-30
MX/a/2008/003100
Filed on 2006-08-30
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
Japan
2008-529228
Filed on 2006-08-30
2008-529228
Filed on 2006-08-30
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
European Patent
06813945.0
Filed on 2006-08-30
06813945.0
Filed on 2006-08-30
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
China
200680040307.8
Filed on 2006-08-30
200680040307.8
Filed on 2006-08-30